Calcipotriol cream in the morning and ointment in the evening: A novel regimen to improve compliance

Journal of Dermatological Treatment

Volumn 12, Issue 2, 2001, Pages 75-79

  Van de Kerkhof, P C M ^a   Franssen, M ^a   De La Brassine, M ^a   Kuipers, M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcipotriol; Compliance; Psoriasis

Indexed keywords

CALCIPOTRIOL; DAIVONEX CREAM; DAIVONEX OINTMENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CREAM; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OINTMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSORIASIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITRIOL; CHILD; DERMATOLOGIC AGENTS; DOSAGE FORMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PATIENT COMPLIANCE; PSORIASIS; TREATMENT OUTCOME;

EID: 0034775722     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466301317085345     Document Type: Article

References (9)

1. Efficacy and safety of calcipotriol (MC903) ointment in psoriasis vulgaris
2. Comparative effects of two different calcipotriol (MC903) cream formulations versus placebo in psoriasis vulgaris. A randomised double-blind, placebo controlled, parallel group multi-centre study
3. 3) on cutaneous inflammation, epidermal proliferation and keratinisation in psoriasis; a placebo controlled double-blind study
4. Evaluation of topical drug treatment in psoriasis
5. Actualiseringsronde NHG-standaarden 1995-1996
6. Daivonex ointment twice daily versus Daivonex cream in the morning and Daivonex ointment in the evening
7. Understanding and enhancing patient compliance with diabetic regimens
8. Patient compliance and disease management in the treatment of psoriasis in the Netherlands
9. 3 analogues